Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (22)

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

2022

  1. Immunomodulatory effect of a very-low-calorie ketogenic diet compared with bariatric surgery and a low-calorie diet in patients with excessive body weight

    Clinical Nutrition, Vol. 41, Núm. 7, pp. 1566-1577

2020

  1. A consensus on the diagnosis and treatment of acromegaly comorbidities: An update

    Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E937-E946

  2. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77

2019

  1. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants

    International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i

2017

  1. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

    The Lancet, Vol. 389, Núm. 10064, pp. 37-55

  2. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

    The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642

2016

  1. A century of trends in adult human height

    eLife, Vol. 5

  2. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants

    The Lancet, Vol. 387, Núm. 10026, pp. 1377-1396

  3. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants

    The Lancet, Vol. 387, Núm. 10027

  4. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants

    The Lancet, Vol. 387, Núm. 10027, pp. 1513-1530

2015

  1. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants

    The Lancet Diabetes and Endocrinology, Vol. 3, Núm. 8, pp. 624-637

  2. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460

2014

  1. White fish reduces cardiovascular risk factors in patients with metabolic syndrome: The WISH-CARE study, a multicenter randomized clinical trial

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 3, pp. 328-335

2013

  1. Pegvisomant and cabergoline combination therapy in acromegaly

    Pituitary, Vol. 16, Núm. 1, pp. 101-108

2010

  1. Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 5, pp. 2147-2154

  2. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229

2004

  1. Expression of Ghrelin and Its Functional Receptor, the Type 1a Growth Hormone Secretagogue Receptor, in Normal Human Testis and Testicular Tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 89, Núm. 1, pp. 400-409